| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |